D.E. Shaw & Co’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $265K | Sell |
|
|||||
|
2023
Q3 | $345K | Sell |
|
|||||
|
2023
Q2 | $919K | Buy |
|
|||||
|
2023
Q1 | $1.13M | Buy |
|
|||||
|
2022
Q4 | $617K | Sell |
|
|||||
|
2022
Q3 | $1.82M | Sell |
|
|||||
|
2022
Q2 | $2.06M | Buy |
|
|||||
|
2022
Q1 | $967K | Buy |
|
|||||
|
2021
Q4 | $1.06M | Buy |
|
|||||
|
2021
Q3 | $948K | Sell |
|
|||||
|
2021
Q2 | $890K | Buy |
|
|||||
|
2021
Q1 | $296K | Buy |
|